Pages that link to "Q73335132"

The following pages link to Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines (Q73335132):

Displaying 45 items.

• Genetic variation in the progesterone receptor gene and ovarian cancer risk (Q24540482) (← links)
• Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line (Q24791221) (← links)
• Estrogen, progesterone and epithelial ovarian cancer (Q24805637) (← links)
• The Effect of Breastfeeding Duration and Parity on the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis (Q28066985) (← links)
• Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis (Q28137887) (← links)
• Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling (Q28304574) (← links)
• Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer (Q33309499) (← links)
• Hormonal interactions in ovarian cancer (Q33541940) (← links)
• Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events (Q34200707) (← links)
• Protective Effect of Progesterone during Pregnancy against Ovarian Cancer (Q34305384) (← links)
• Hormone replacement therapy (HRT) in women after genital cancer (Q34602929) (← links)
• Progesterone action in breast, uterine, and ovarian cancers (Q35108906) (← links)
• Progesterone as a regulator of granulosa cell viability (Q35207730) (← links)
• Progesterone inhibits the growth of human neuroblastoma: in vitro and in vivo evidence (Q35286790) (← links)
• Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort (Q35565269) (← links)
• The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells (Q35674453) (← links)
• Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis (Q35983656) (← links)
• Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells (Q36367092) (← links)
• Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. (Q36906210) (← links)
• Hormone response in ovarian cancer: time to reconsider as a clinical target? (Q36966197) (← links)
• In vivo and in vitro studies on apoptosis in OSE cells and inclusion cysts of pregnant heifers (Q37063097) (← links)
• Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women (Q37145818) (← links)
• Estrous cycle modulates ovarian carcinoma growth. (Q37345175) (← links)
• Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice. (Q37379342) (← links)
• Current understanding of risk factors for ovarian cancer (Q37551696) (← links)
• Steroid hormone receptors in cancer development: A target for cancer therapeutics (Q37798330) (← links)
• Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis (Q38499888) (← links)
• Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species (Q39617962) (← links)
• Antisense oligonucleotide to insulin-like growth factor II induces apoptosis in human ovarian cancer AO cell line (Q41024358) (← links)
• Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins (Q41080829) (← links)
• Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells (Q42517539) (← links)
• Medroxyprogesterone acetate alone or synergistic with chemotherapy suppresses colony formation and DNA synthesis in C6 glioma in vitro (Q43766275) (← links)
• Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women (Q44011321) (← links)
• Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL (Q44611177) (← links)
• Nuclear receptor DAX‐1 in human common epithelial ovarian carcinoma: An independent prognostic factor of clinical outcome (Q44651418) (← links)
• Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone (Q44669637) (← links)
• Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells (Q46418281) (← links)
• Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women (Q57463812) (← links)
• In vitro antitumor activity of progesterone in human adrenocortical carcinoma (Q58113724) (← links)
• Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma (Q61442985) (← links)
• Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer (Q61797432) (← links)
• Increased radiation-induced chromosome breakage after progesterone addition at the G1/S-phase transition (Q77190450) (← links)
• Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (Q92860654) (← links)
• Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis (Q93023196) (← links)
• Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation (Q100430759) (← links)